Session

Endoscopic submucosal dissection: Technique and outcomes

PROSPECTIVE SINGLE-ARM TRIAL ON FEASIBILITY AND SAFETY OF NOVEL ENDOSCOPIC ROBOTIC SYSTEM (ENDOMASTER) FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION
PROSPECTIVE SINGLE-ARM TRIAL ON FEASIBILITY AND SAFETY OF NOVEL ENDOSCOPIC ROBOTIC SYSTEM (ENDOMASTER) FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION

HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION VS. CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEOPLASMS; A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (HYBRID-G TRIAL)
HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION VS. CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEOPLASMS; A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (HYBRID-G TRIAL)

RISK OF RESIDUAL NEOPLASIA AFTER A NON-CURATIVE COLORECTAL ESD FOR MALIGNANT LESIONS; A MULTINATIONAL STUDY
RISK OF RESIDUAL NEOPLASIA AFTER A NON-CURATIVE COLORECTAL ESD FOR MALIGNANT LESIONS; A MULTINATIONAL STUDY

MUSCULAR RETRACTION SIGN (MRS): A PREDICTIVE FACTOR OF NON-CURATIVE COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD)? RESULTS OF A PROSPECTIVE STUDY IN AN EXPERT CENTER
MUSCULAR RETRACTION SIGN (MRS): A PREDICTIVE FACTOR OF NON-CURATIVE COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD)? RESULTS OF A PROSPECTIVE STUDY IN AN EXPERT CENTER

VONOPRAZAN 3 WEEKS TREATMENT IS NOT INFERIOR TO 8 WEEKS TREATMENT FOR THE MANAGEMENT AFTER GASTRIC ESD: A MULTICENTER RANDOMIZED NON-INFERIORITY STUDY
VONOPRAZAN 3 WEEKS TREATMENT IS NOT INFERIOR TO 8 WEEKS TREATMENT FOR THE MANAGEMENT AFTER GASTRIC ESD: A MULTICENTER RANDOMIZED NON-INFERIORITY STUDY

VONOPRAZAN 3 WEEKS TREATMENT IS NOT INFERIOR TO 8 WEEKS TREATMENT FOR THE MANAGEMENT AFTER GASTRIC ESD: A MULTICENTER RANDOMIZED NON-INFERIORITY STUDY
VONOPRAZAN 3 WEEKS TREATMENT IS NOT INFERIOR TO 8 WEEKS TREATMENT FOR THE MANAGEMENT AFTER GASTRIC ESD: A MULTICENTER RANDOMIZED NON-INFERIORITY STUDY

Endoscopic submucosal dissection: Technique and outcomes  et al.

MUSCULAR RETRACTION SIGN (MRS): A PREDICTIVE FACTOR OF NON-CURATIVE COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD)? RESULTS OF A PROSPECTIVE STUDY IN AN EXPERT CENTER
MUSCULAR RETRACTION SIGN (MRS): A PREDICTIVE FACTOR OF NON-CURATIVE COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD)? RESULTS OF A PROSPECTIVE STUDY IN AN EXPERT CENTER

Endoscopic submucosal dissection: Technique and outcomes  et al.

RISK OF RESIDUAL NEOPLASIA AFTER A NON-CURATIVE COLORECTAL ESD FOR MALIGNANT LESIONS; A MULTINATIONAL STUDY
RISK OF RESIDUAL NEOPLASIA AFTER A NON-CURATIVE COLORECTAL ESD FOR MALIGNANT LESIONS; A MULTINATIONAL STUDY

Endoscopic submucosal dissection: Technique and outcomes  et al.

HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION VS. CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEOPLASMS; A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (HYBRID-G TRIAL)
HYBRID ENDOSCOPIC SUBMUCOSAL DISSECTION VS. CONVENTIONAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEOPLASMS; A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL (HYBRID-G TRIAL)

Endoscopic submucosal dissection: Technique and outcomes  et al.

PROSPECTIVE SINGLE-ARM TRIAL ON FEASIBILITY AND SAFETY OF NOVEL ENDOSCOPIC ROBOTIC SYSTEM (ENDOMASTER) FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION
PROSPECTIVE SINGLE-ARM TRIAL ON FEASIBILITY AND SAFETY OF NOVEL ENDOSCOPIC ROBOTIC SYSTEM (ENDOMASTER) FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION

Endoscopic submucosal dissection: Technique and outcomes  et al.

Item 1 - 10 / 10
1